• Nenhum resultado encontrado

Methylation of the claudin 1 promoter is associated with loss of expression in estrogen receptor positive breast cancer.

N/A
N/A
Protected

Academic year: 2016

Share "Methylation of the claudin 1 promoter is associated with loss of expression in estrogen receptor positive breast cancer."

Copied!
8
0
0

Texto

Loading

Referências

Documentos relacionados

Increased expression of Rev3 in human breast epithelial cancer cell lines compared to non- neoplastic human breast epithelial cells MCF-12A, and in human breast tumors compared

To gain an insight into the contribution of gene promoter methylation toward aberrant expression of RASSF3, we studied RASSF3 methylation status and its expression level in normal

Enhancement of insulin-like growth factor signaling in human breast cancer: estrogen regulation of insulin receptor substrate-1 expression in vitro and in vivo.. Activation

Fig 1. Regulation of RPRM expression by methylation of its promoter region. A) RPRM promoter region analyzed by bisulfite quantification. B) DNA Bisulfite sequencing in gastric

Here, we characterized gene expression (mRNA and protein levels) of MTAP and CDKN2A in seven breast cancer cell lines and performed a promoter methylation analysis of MTAP ( Fig 3

We not only verified the ectopic expression of Vav1 in human breast cancer cell lines, but also observed that Vav1 expression was induced by 17b-estradiol (E 2 ), a typical

Differential mRNA expression of tight junction (Occludin, ZO-1, Claudin 1, Claudin 7) and adherence junctions ( a - catenin, b -catenin and E-cadherin) in prostate cancer cell

To determine the poten- tial role of Bmi-1 in regulation of IR-induced vimentin expression and EMT of breast cancer cells, we analyzed the correlation of the expression levels of